MitsuoOkadaTsuneyoshiYao<. Get access to over 12 million other articles!" />
TITLE

Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity indexMitsuruSeoMitsuoOkadaTsuneyoshiYao<

AUTHOR(S)
Seo, Mitsuru; Okada, Mitsuo; Yao, Tsuneyoshi; Matake, Hiroaki; Maeda, Kazuhiro
PUB. DATE
January 2002
SOURCE
Journal of Gastroenterology;2002, Vol. 37 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on a study which evaluated the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. Patients and methods; Results; Discussion of findings.
ACCESSION #
5980611

 

Related Articles

  • Single-Incision Total Proctocolectomy and Ileal Pouch Anal Anastomosis in Pediatric Patients: Lessons Learned. Schlager, Avraham; Siddharthan, Ragavan V.; Santore, Matthew T.; Balci, Ozlem; Clifton, Matthew S.; Heiss, Kurt F. // Journal of Laparoendoscopic & Advanced Surgical Techniques;Sep2015, Vol. 25 Issue 9, p782 

    Background: Total proctocolectomy (TPC) and ileal pouch anal anastomosis (IPAA) have become the standard of care for patients with ulcerative colitis refractory to medical management. The purpose of our study is to show our single-site approach and to identify maneuvers that improve...

  • Controlled-release mesalamine maintains remission in ulcerative colitis.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p52 

    Presents an abstract of the article titled `Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis,' by P. Miner, S. Hanauer, M. Robinson et al originally published in the February 1995 issue of `Digest of Diseases in Science.'

  • Soothe gut feelings. Munson, Marty; Yeykal, Teresa A. // Prevention;Aug94, Vol. 46 Issue 8, p36 

    States that new research suggests that `the patch' used by smokers may also be used to treat ulcerative colitis (UC). How it works is a bit of a mystery, but one theory suggests it may increase a natural anti-inflammatory hormone, called cortisol; Report in `New England Journal of Medicine,'...

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie, D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p121 

    A review of the article "Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomized controlled trial," by D. Laharie and colleagues, which appeared in the 2012 issue of "Groupe d'Etudes Thérapeutiques des...

  • Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Kaplan, G. C. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p122 

    A review of the article "Decreasing colectomy rates for ulcerative colitis: A population-based time trend study," by G. G. Kaplan and colleagues, which appeared in the "American Journal of Gastroenterology" in the 2012 issue is presented.

  • Balsalazide: A Viewpoint by Jonathan R.B. Green. Green, J.R.B. // Drugs;Jul1998, Vol. 56 Issue 1, p90 

    Comments on the effectiveness of the drug balsalazide for the acute relapse of ulcerative colitis. Effectiveness of the drug; Potential of the drug as a treatment for ulcerative colitis.

  • Balsalazide. Prakash, A.; Spencer, C.M. // Drugs;Jul1998, Vol. 56 Issue 1, p83 

    â–´ Balsalazide is a prodrug of mesalazine which has an inert carrier molecule instead of the sulfapyridine moiety of sulfasalazine. â–´ Balsalazide 6.75 g/day was more effective than mesalazine 2.4 g/day in at least 1 trial and as effective as sulfasalazine 3 g/day for inducing...

  • Maintenance drug for ulcerative colitis.  // Modern Medicine;Oct97, Vol. 65 Issue 10, p37 

    Reports that mesalamine has been cleared for the maintenance of remission in patients with ulcerative colitis.

  • Diosmectite for Ulcerative Colitis: A Pilot Trial. Guslandi, M. // Clinical Drug Investigation;1998, Vol. 16 Issue 5, p411 

    Presents the findings of a pilot study in which the possible therapeutic effect of diosmectite was investigated in patients with mild to moderate ulcerative colitis. Factors that may play a pathogenetic role in ulcerative colitis; Treatment regimen; Absence of significant beneficial effects...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics